Keppra - 50474-002-63 - (levetiracetam)

Alphabetical Index


Drug Information of Keppra

Product NDC: 50474-002
Proprietary Name: Keppra
Non Proprietary Name: levetiracetam
Active Ingredient(s): 100    mg/mL & nbsp;   levetiracetam
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION, CONCENTRATE
Coding System: National Drug Codes(NDC)

Labeler Information of Keppra

Product NDC: 50474-002
Labeler Name: UCB, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021872
Marketing Category: NDA
Start Marketing Date: 20060823

Package Information of Keppra

Package NDC: 50474-002-63
Package Description: 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) > 5 mL in 1 VIAL, SINGLE-USE

NDC Information of Keppra

NDC Code 50474-002-63
Proprietary Name Keppra
Package Description 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) > 5 mL in 1 VIAL, SINGLE-USE
Product NDC 50474-002
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name levetiracetam
Dosage Form Name INJECTION, SOLUTION, CONCENTRATE
Route Name INTRAVENOUS
Start Marketing Date 20060823
Marketing Category Name NDA
Labeler Name UCB, Inc.
Substance Name LEVETIRACETAM
Strength Number 100
Strength Unit mg/mL
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]

Complete Information of Keppra


General Information